Increase efficiencies and productivity by automating core reporting tasks for medical writing.
Automate core regulatory report documents across the CTD pyramid and dramatically accelerate submission timelines.
In the ever-evolving pharmaceutical landscape, the integration of artificial intelligence (AI) in clinical trials is a game-changer, enhancing efficiency and effectiveness. By exploring the advantages of AI in late-stage drug development, we reveal how AI optimizes clinical trials, streamlines data collection, and improves patient recruitment and retention. Dive in to discover how AI can transform your drug development process and position your organization at the forefront of innovation.
The Transformative Power of AI in Late-Stage Drug Development Read More »
Listen to the ninth episode of AI Uncovered with Rohit Sood
AI Uncovered with Rohit Sood (Digital Transformation & AI’s Role in Life Sciences) Read More »
Discover how Yseop, a French start-up, teams up with AWS to revolutionize clinical trials using AI for faster drug development.
This French start-up wants to use AI to develop new medicines more quickly Read More »
Discover the transformative potential of Generative AI in pharmaceuticals. Dive into five essential steps for implementation and investment, from leveraging competitive advantages to ensuring compliance with industry standards. Unveil the future of Pharma innovation with Generative AI.
Generative AI for Pharma: 5 Steps for Implementation & Investment Read More »
Natural language generation (NLG) is a critical piece of AI. Specifically, NLG is a subsection of Natural Language Processing (NLP). NLG software turns structured data into written reports, providing explanations and narratives at a rapid pace. We’ve seen many advancements stemming from NLG. In this blog post, we’ll discuss what’s new in natural language generation in AI.Â
Latest Innovations in Natural Language Generation in AI Read More »